Today: 1 May 2026
Alibaba stock drops into the weekend as China opens food-delivery probe; what BABA traders watch next
11 January 2026
1 min read

Alibaba stock drops into the weekend as China opens food-delivery probe; what BABA traders watch next

New York, January 11, 2026, 11:18 (EST) — Market closed.

Alibaba Group Holding’s U.S.-listed ADRs dropped 2.3%, closing at $150.96 on Friday. The decline came after China announced an investigation into aggressive competition among food-delivery platforms, drawing attention to the subsidy-heavy “instant retail” battle for one-hour delivery of products—from meals to over-the-counter medicine. Both Alibaba and rival Meituan said they welcome the probe and will cooperate. Reuters

This move matters now because delivery stands out as one of the clearest areas where Alibaba can boost user growth amid China’s packed consumer internet scene. It’s also a quick way to burn cash, making markets jittery about any spending shifts as U.S. trading kicks off again on Monday.

There’s a bigger issue here: policymakers aim to temper price wars without slashing demand. For Alibaba, this could translate into fewer discounts, rising compliance expenses, or pressure to alter its approach to merchants and couriers. None of that bodes well for neat forecasts.

China’s State Council announced the assessment will involve on-site inspections, interviews, and questionnaires, gathering input from merchants, workers, and consumers ahead of any proposed corrective steps. The commission in charge called on platforms to boost antitrust compliance and ensure fair competition.

The industry has been caught in a discount spiral for months. Kenneth Fong of UBS Investment Bank described the rivalry as a “high-stakes ‘game of chicken’,” while Moody’s Ratings analyst Ying Wang suggested that companies’ pledges to curb “involution” might “gradually rationalise” competition. Reuters

Alibaba highlighted faster delivery as a key growth driver. In November, the company surpassed quarterly revenue forecasts, boosted by investments in one-hour delivery that attracted more users to its shopping apps. Its cloud division also showed robust growth.

Rivals find themselves locked in the same battle. Meituan posted its first quarterly loss since late 2022 and signaled more losses ahead as a fierce price war with Alibaba and JD.com erodes margins, highlighting just how fast promotions can drain profits.

As the week kicks off, traders are on alert for any hint the regulator’s probe is shifting gears — whether that means softer subsidy offers, tougher merchant terms, or discussions around service-quality rules that could boost costs. If Alibaba changes course, it’ll probably surface first in tweaks to app traffic strategies and marketing budgets, rather than a big announcement.

The investigation cuts both ways. If platforms retreat too much, order growth could stall, pushing the battle toward other tactics — exclusive deals, delivery fees, or merchant commissions — which risk new scrutiny and consumer pushback. On the flip side, if Beijing falls short on effective measures, the price war could drag on, keeping margins razor-thin.

Alibaba’s upcoming quarterly earnings, slated for about Feb. 19 per Nasdaq’s earnings calendar, stand as the next major trigger for its stock.

Stock Market Today

  • Applied Materials Valuation Diverges Amid Strong Shareholder Returns
    April 30, 2026, 7:41 PM EDT. Applied Materials (AMAT) has shown 46.72% year-to-date and 167.20% one-year total shareholder returns, signaling strong momentum despite recent short-term pressure. At a current share price of $394.49, the stock trades substantially above a typical fair value estimate of $194.11, which suggests it may be overvalued by about 103%. Analysts cite growth driven by AI, high-performance computing, and automotive chips, along with anticipated profit margin expansion, to justify higher valuations. However, risks such as tighter export controls on China and a semiconductor capex slowdown could undermine these growth assumptions. Investors are advised to weigh potential rewards against warning signs amid differing market views on Applied Materials' future performance.

Latest article

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

1 May 2026
Sandisk shares dropped about 6% in after-hours trading Thursday despite reporting fiscal Q3 revenue of $5.95 billion, up 251% from a year earlier, and net income of $3.62 billion. The company announced a $6 billion buyback and forecast Q4 revenue of up to $8.25 billion. Gross margin rose to 78.4%. Shares had closed at $1,096.51 before slipping to about $1,030.
Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

1 May 2026
Apple reported fiscal Q2 revenue of $111.2 billion and earnings of $2.01 per share, beating analyst estimates. The board approved a $100 billion share buyback and raised the dividend. Shares fell about 1% after hours as iPhone sales missed forecasts and chip supply remained tight. Investors are watching for clarity on AI strategy and the upcoming CEO transition to John Ternus.
Nvidia Stock Falls as Google and Amazon AI Chip Push Tests the AI Trade

Nvidia Stock Falls as Google and Amazon AI Chip Push Tests the AI Trade

30 April 2026
Nvidia shares dropped 4.6% to $199.57 Thursday as investors reacted to Alphabet and Amazon expanding sales of their own AI chips. Alphabet reported Google Cloud revenue up 63% and began selling TPU chips directly to customers. AMD and Broadcom shares rose 5.1% and 3.0%, respectively. Amazon said its Trainium chip line secured $225 billion in revenue commitments.
Tencent Holdings stock: buyback keeps pressure on bears as AI bottleneck warning hits tape
Previous Story

Tencent Holdings stock: buyback keeps pressure on bears as AI bottleneck warning hits tape

Roche stock: $570 million MediLink cancer-drug deal puts Swiss shares back in focus
Next Story

Roche stock: $570 million MediLink cancer-drug deal puts Swiss shares back in focus

Go toTop